Status:
COMPLETED
Atelectasis Formation Using HFJV During Stereotactic Solid Organ Ablations
Lead Sponsor:
Karolinska Institutet
Conditions:
High Frequency Jet Ventilation
Atelectasis
Eligibility:
All Genders
50+ years
Brief Summary
Atelectasis formation using HFJV during stereotactic solid organ ablations. Primary endpoint will be to study the formation of atelectasis during HFJV. Secondary endpoint will be to study liver displ...
Detailed Description
The use of HFJV in abdominal surgery as well as in out-of-operating theatre environment, is not well studied. In percutaneous liver thermal ablation the patient is anesthetized and intubated on the CT...
Eligibility Criteria
Inclusion
- All consecutive patients admitted to and by the surgeon planned for liver thermal ablation with cascination navigation system (requiring high frequency jet ventilation) from start date 25th of October, until a total number of 25 patients are included.
Exclusion
- Age \< 50 years old. Severe lung disease.
Key Trial Info
Start Date :
October 2 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 19 2017
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT03378752
Start Date
October 2 2017
End Date
December 19 2017
Last Update
August 8 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska Institute Danderyd Hospital
Stockholm, Sweden, 18288